Compare SERA & MCAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SERA | MCAH |
|---|---|---|
| Founded | 2008 | 2026 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.2M | 86.5M |
| IPO Year | 2021 | 2026 |
| Metric | SERA | MCAH |
|---|---|---|
| Price | $2.10 | $10.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | 16.1K | ★ 75.3K |
| Earning Date | 11-12-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.32 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $81,000.00 | N/A |
| Revenue This Year | $177.78 | N/A |
| Revenue Next Year | $755.56 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 5.19 | N/A |
| 52 Week Low | $1.56 | $9.92 |
| 52 Week High | $3.95 | $11.04 |
| Indicator | SERA | MCAH |
|---|---|---|
| Relative Strength Index (RSI) | 53.77 | 64.00 |
| Support Level | $1.96 | $10.00 |
| Resistance Level | $2.21 | $11.04 |
| Average True Range (ATR) | 0.09 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 47.14 | 100.00 |
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
Mountain Crest Acquisition 6 Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.